Arbutus Biopharma Corp (ABUS)
2.74
+0.02
(+0.74%)
USD |
NASDAQ |
Apr 26, 13:34
Arbutus Biopharma Free Cash Flow (Quarterly): -17.29M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -17.29M |
| September 30, 2023 | -21.82M |
| June 30, 2023 | -20.42M |
| March 31, 2023 | -27.42M |
| December 31, 2022 | -17.12M |
| September 30, 2022 | -18.78M |
| June 30, 2022 | -20.50M |
| March 31, 2022 | 20.54M |
| December 31, 2021 | -19.66M |
| September 30, 2021 | -16.06M |
| June 30, 2021 | -14.64M |
| March 31, 2021 | -17.98M |
| December 31, 2020 | -15.16M |
| September 30, 2020 | -12.18M |
| June 30, 2020 | -8.867M |
| March 31, 2020 | -15.45M |
| December 31, 2019 | -13.41M |
| September 30, 2019 | -23.72M |
| June 30, 2019 | -17.84M |
| March 31, 2019 | -16.61M |
| December 31, 2018 | -17.30M |
| September 30, 2018 | -13.44M |
| June 30, 2018 | -18.05M |
| March 31, 2018 | -20.22M |
| December 31, 2017 | -10.53M |
| Date | Value |
|---|---|
| September 30, 2017 | -16.22M |
| June 30, 2017 | -8.198M |
| March 31, 2017 | -20.96M |
| December 31, 2016 | -17.42M |
| September 30, 2016 | -14.88M |
| June 30, 2016 | -17.76M |
| March 31, 2016 | -11.82M |
| December 31, 2015 | -19.39M |
| September 30, 2015 | -3.116M |
| June 30, 2015 | -18.18M |
| March 31, 2015 | -17.98M |
| December 31, 2014 | -7.169M |
| September 30, 2014 | -6.872M |
| June 30, 2014 | -8.256M |
| March 31, 2014 | 8.82M |
| December 31, 2013 | 2.373M |
| September 30, 2013 | -3.79M |
| June 30, 2013 | -3.004M |
| March 31, 2013 | -3.041M |
| December 31, 2012 | 40.36M |
| September 30, 2012 | -1.514M |
| June 30, 2012 | -1.686M |
| March 31, 2012 | -4.263M |
| December 31, 2011 | -0.4522M |
| September 30, 2011 | -0.0561M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-27.42M
Minimum
Mar 2023
20.54M
Maximum
Mar 2022
-15.67M
Average
-17.29M
Median
Dec 2023
Free Cash Flow (Quarterly) Benchmarks
| Moderna Inc | 402.00M |
| Pacira BioSciences Inc | 45.79M |
| Chimerix Inc | -14.59M |
| Karyopharm Therapeutics Inc | -18.58M |
| Corvus Pharmaceuticals Inc | -5.167M |